Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lepidium Meyenii Root Extract,Choline,Magnesium
Therapeutic Area : Musculoskeletal
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : WHITNEY JOHNS ACTIVE (lepidium meyenii root extract) proven all-natural BPF Gold Citrus Bergamot SuperFruit™ formulation, has been clinically proven to increase NO by 73% and oxygen consumption by 24%, thereby enhancing physical performance and the ben...
Brand Name : Active
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 22, 2022
Lead Product(s) : Lepidium Meyenii Root Extract,Choline,Magnesium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Trial investigate ability of UBN RELIEF™ to naturally prevent or alleviate symptoms associated with migraines while improving cognitive function. UBN RELIEF is based on specialized version of Healthy Extracts’ proprietary, patent-protected Fuel4Thoug...
Brand Name : UBN RELIEF
Molecule Type : Small molecule
Upfront Cash : Not Applicable
September 22, 2021
Details : UBN RELIEF promotes brain health and wellbeing in migraine sufferers supporting 61% shorter symptom duration, 60% less missed work days, 41% reduction of light and sound sensitivity, and 39% fewer pain episodes when taken on a daily basis.
Brand Name : UBN RELIEF
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 31, 2021
Details : Clinical studies have shown ACTIVATE dramatically improves human cognitive behavior and mental focus by activating areas of the brain primarily responsible for attention, memory, mood, and quick reaction times.
Brand Name : UBN Activate
Molecule Type : Small molecule
Upfront Cash : Not Applicable
July 08, 2021
LOOKING FOR A SUPPLIER?